Tacrolimus in refractory patients with myasthenia gravis: Coadministration and tapering of oral prednisolone

Journal of Clinical Neuroscience

Volumn 13, Issue 1, 2006, Pages 39-44

  Shimojima, Yasuhiro ^a   Matsuda, Masayuki ^a   Gono, Takahisa ^a   Ishii, Wataru ^a   Tokuda, Takahiko ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti acetylcholine receptor antibody; Myasthenia gravis; Prednisolone; Tacrolimus; Thymectomy

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; OSTEOPOROSIS; POLYMYOSITIS; PRIORITY JOURNAL; RIB FRACTURE; SCORING SYSTEM; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMECTOMY;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISOLONE; PROSPECTIVE STUDIES; RECEPTORS, CHOLINERGIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 30344478845     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.12.008     Document Type: Article

References (19)

1. D.P. Richman, and M.A. Agius Treatment of autoimmune myasthenia gravis Neurology 61 2003 1652 1661
2. N. Wakata, T. Saito, S. Tanaka, T. Hirano, and K. Oka Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis Clin Neurol Neurosurg 106 2003 5 8
3. T. Konishi, Y. Yoshiyama, M. Takamori, K. Yagi, E. Mukai, and T. Saida Japanese FK506 MG Study Group. Clinical study of FK506 in patients with myasthenia gravis Muscle Nerve 28 2003 570 574
4. H. Yoshikawa, K. Mabuchi, Y. Yasukawa, M. Takamori, and M. Yamada Low-dose tacrolimus for intractable myasthenia gravis J Clin Neurosci 9 2002 627 628
5. K. Utsugisawa, Y. Nagane, H. Yonezawa, D. Obara, R. Kondoh, and H. Tohgi Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells Muscle Nerve 27 2003 245 248
6. S.L. Schreiber, and G.R. Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 1992 136 142
7. M.J. Tocci, D.A. Matkovich, and K.A. Collier The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes J Immunol 143 1989 718 726
8. A. Jaretzki, R.J. Barohn, and R.M. Ernstoff Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America Neurology 55 2000 16 23
9. G.I. Wolfe, L. Herbelin, S.P. Nations, B. Foster, W.W. Bryan, and R.J. Barohn Myasthenia gravis activities of daily living profile Neurology 52 1999 1487 1489
10. Y. Monden, T. Uyama, and K. Nakahara Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases Ann Thorac Surg 41 1986 189 192
11. M. Ciaccio, A. Parodi, and A. Rebora Myasthenia gravis and lupus erythematosus Int J Dermatol 28 1989 317 320
12. M.T. Palmisani, A. Evoli, A.P. Batocchi, E. Bartoccioni, and P. Tonali Myasthenia gravis and associated autoimmune diseases Muscle Nerve 17 1994 1234 1235
13. C.V. Oddis, F.C. Sciurba, K.A. Elmagd, and T.E. Starzl Tacrolimus in refractory polymyositis with interstitial lung disease Lancet 353 1999 1762 1763
14. A. Evoli, C. Di Schino, F. Marsili, and C. Punzi Successful treatment of myasthenia gravis with tacrolimus Muscle Nerve 25 2002 111 114
15. K. Falkiewicz, W. Nahaczewska, and M. Boratynska Tacrolimus decreases tubular phosphate wasting in renal allograft recipients Transplant Proc 35 2003 2213 2215
16. D.E. Yocum, D.E. Furst, and J.L. Kaine Efficacy and safety of tacrolimus in patients with rheumatoid arthritis. A double-blind trial Arthritis Rheum 48 2003 3328 3337
17. Y.-M. Ning, and E.R. Sanchez Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin J Biol Chem 268 1993 6073 6076
18. M. Takamori, M. Motomura, and N. Kawaguchi Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis Neurology 62 2004 1894 1896
19. H. Kondo, T. Abe, and H. Hashimoto Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study J Rheumatol 31 2004 243 251